Nipro Corporation (FRA:5FA)

Market Cap	1.37B -7.9%
Revenue (ttm)	3.55B +4.1%
Net Income	82.59M +199.6%
EPS	0.45 +199.6%
Shares Out	n/a
PE Ratio	16.63
Forward PE	n/a
Dividend	0.14 (1.63%)
Ex-Dividend Date	Sep 29, 2025

Volume	n/a
Average Volume	6
Open	8.25
Previous Close	8.40
Day's Range	8.25 - 8.25
52-Week Range	7.30 - 8.95
Beta	n/a
RSI	60.89
Earnings Date	Feb 9, 2026

About Nipro

Nipro Corporation, together with its subsidiaries, engages in the medical devices, pharmaceuticals, and pharma packaging businesses. Its Medical-Related business develops, manufactures, and sells injection and infusion products, artificial organ-related products, functional products, dialysis products, cell cultures, hospital products, diabetic products, and pharmaceuticals comprising generic and kit products; and manufactures medical equipment, including dialysis medical device products; and operates dialysis and training centers. The company’...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1947
• Employees: 39,168
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 5FA

Financial Performance

In fiscal year 2025, Nipro's revenue was 644.59 billion, an increase of 9.85% compared to the previous year's 586.79 billion. Earnings were 5.11 billion, a decrease of -53.97%.

Financial numbers in JPY